Literature DB >> 30217885

Retraction: Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer.

.   

Abstract

Entities:  

Year:  2018        PMID： 30217885     DOI： 10.1158/0008-5472.CAN-18-1165

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  1 in total

1.  Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway.

Authors:  Minghai Shao; Caiping Jiang; Changhui Yu; Haijian Jia; Yanli Wang; Xinli Mao
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.